[PLACE]
open‑angle glaucoma
Featured in 1 tracked story · first seen
Situations
Life Biosciences ER-100 eye gene therapy trial
9 clusters · 33 sources · last updated
Latest: Life Biosciences' ER‑100 Gene Therapy Administered to First Patient for Glaucoma
The Phase‑1 safety study of Life Biosciences’ ER‑100 eye‑gene therapy moved from its inaugural dose on 9 June 2026 to active enrollment by mid‑July, targeting up to 18 adults with open‑angle glaucoma or non‑arteritic ant